Indoles as gut microbial pharmaco-metabolites : targets, mechanisms and consequences for obesity and cardiometabolic diseases
The gut microbiota play a pivotal role in the onset and development of obesity and cardiometabolic disorders. Obese subjects exhibit significant gut microbial changes, including enrichment for bacterial genes associated with the degradation of tryptophan, which is converted by gut bacteria into indo...
Main Author: | Fernandes Neves Soares, Ana Luísa |
---|---|
Other Authors: | Dumas, Marc-Emmanuel ; Nicholson, Jeremy |
Published: |
Imperial College London
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.739677 |
Similar Items
-
Novel antitumor microbial metabolites obtained through the mechanism-oriented screening
by: Ishii, Takafumi
Published: (2011) -
The Interaction between Mitochondrial Oxidative Stress and Gut Microbiota in the Cardiometabolic Consequences in Diet-Induced Obese Rats
by: Adriana Ortega-Hernández, et al.
Published: (2020-07-01) -
Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis
by: Dereje Abate Negatu, et al.
Published: (2019-03-01) -
The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health
by: Lenka Tomasova, et al.
Published: (2021-07-01) -
Gut microbial-host metabolic interactions following bariatric surgery
by: Phetcharaburanin, Jutarop
Published: (2018)